Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Vet Parasitol ; 323: 110022, 2023 Sep 04.
Artículo en Inglés | MEDLINE | ID: mdl-37757631

RESUMEN

We aimed to validate a targeted selective treatment (TST) methodology for treating parasitic gastrointestinal infections in ewes in different physiological states using parasitological and hematological parameters. Forty ewes were monitored from December 2021 to June 2022 and evaluated during various physiological stages in their life cycle. Before starting the experiment, a fecal egg count (FEC) reduction test was performed to evaluate the efficacy of the anthelmintic (AH) treatment. Weekly assessments were performed based on the Famacha© (F) system and body condition score (BCS), and ewes were subjected to AH treatment when necessary, with their physiological states recorded. Ewes were treated when they presented F ≥ 3, BCS ≤ 2.0 (when F = 2), or submandibular edema. Parasitological, i.e., FEC, and hematological, i.e., hematocrit (Ht), parameters were evaluated monthly to determine the efficiency of the TST methodology. Comparisons between the mean Ht and FEC values in ewes subjected to AH treatment and untreated ewes were performed using analysis of variance, followed by Tukey's test. Spearman's correlation was performed to determine the correlation between the variables, i.e., F scores, BCS, Ht, and FEC. All tests were performed at a significance level of 5 %. During the experimental period, 1138 evaluations were performed. The main reason for AH treatment was F ≥ 3. Ewes in early pregnancy, lactation and late pregnancy received comparatively more AH treatments than the other physiological states. Ewes in late pregnancy and lactation exhibited lower mean Ht values (23.5 % and 22.9 %) and higher mean FEC values (3269 and 1426) compared with those in early pregnancy (30.2 % and 727 EPG). In addition, a statistically significant difference was observed in the Ht and FEC values of ewes that presented submandibular edema (P < 0.001) compared with those that did not exhibit submandibular edema. The genus Haemonchus sp. showed a 96.4 % prevalence in coprocultures. A positive correlation existed between F scores and FEC (r = 0.3819) and a negative correlation between F scores and Ht (r = -0.4728). Ewes that needed AH treatment had lower mean Ht values than ewes that did not need the treatment (19.2 % × 29.3 %; P < 0.001) and higher mean FEC values (8747 × 1163; P < 0.001), confirming that these ewes needed AH treatment. The TST methodology based on F scores, BCS, and submandibular edema could effectively identify individuals in the herd needing AH treatment, identifying 13 % additional cases requiring treatment than using only the F score criterion.

2.
Res Vet Sci ; 144: 82-91, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-35091165

RESUMEN

This study aimed to evaluate salivary, serum, and abomasal mucus IgA levels in lambs naturally infected with Haemonchus contortus. Thirty-seven crossbred lambs (½ Texel or ½ Ile de France) with an average age of 193 days were evaluated for 56 days after grazing on a contaminated pasture. Fecal samples were collected every 7 days to evaluate the EPG. Blood and saliva samples were collected for IgA measurement every 14 days. On D56, 29 animals were killed for parasite counting and IgA quantification in the abomasal mucus. Salivary, serum, and abomasal mucus IgA were measured by ELISA using third-stage larvae antigens. Salivary and mucus IgA were not correlated, but D14 salivary IgA correlated with EPG on D28 (r = -0.37) and D56 (r = -0.36); D28 salivary IgA correlated with D49 (r = -0.40) and D56 EPG (r = -0.44). Abomasal mucus IgA negatively correlated with EPG from D28 to D56 (r varied from _0.51 to -0.62) and with the counts of all parasitic stages (-0.60 to -0.67). The lambs were classified as susceptible (S) or resistant (R) according to EPG (D56 EPG and cumulative EPG) or IgA (salivary, serum, and mucus IgA). Based on D56 EPG and cumulative EPG, resistant lambs had higher D14 salivary IgA, mucus IgA, and total worm counts. For evaluations based on IgA levels, the EPG of S and R animals differed, indicating that IgA was an immune correlate of protection against natural infection with Haemonchus sp., mainly in the saliva sample of D14.


Asunto(s)
Hemoncosis , Haemonchus , Enfermedades de las Ovejas , Animales , Heces/parasitología , Hemoncosis/veterinaria , Inmunoglobulina A , Moco , Recuento de Huevos de Parásitos/veterinaria , Ovinos , Enfermedades de las Ovejas/parasitología
3.
Vet Parasitol Reg Stud Reports ; 26: 100637, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34879947

RESUMEN

In this study, a three-step experiment was conducted to evaluate the effectiveness of orange essential oil (OEO) to reduce the severity of parasitic infection in lambs naturally infected with gastrointestinal parasites. In the first and second stages of the experiment, the lambs were distributed in groups (n = 10): without treatment (control), treated with levamisole (7.5 mg/kg), and treated either with 200, 300 or 400 mg/kg OEO in the first stage and with two doses of 300 or 350 mg/kg each of OEO with a six-hour interval in the second stage. In the third stage of the experiment, 20 lambs were distributed into control and treated groups (two doses of 350 mg/kg OEO) and slaughtered for determining the parasite count in the abomasum and small intestine. Evaluations were performed on D0, D3, D7, D10, and D14 by determining the egg count per gram of feces (EPG), and the percentage of EPG reduction was calculated in comparison to D0. Coproculture was performed on days D0 and D14 of the first and second stages of the study. In the first stage, the EPG increased by 20.90 and 100.99% and decreased by 5.54% on D14 in the groups treated with 200, 300, or 400 mg/kg OEO, respectively. At the second stage, the EPG of the OEO groups decreased by more than 96% on D3, but on D14 was decreased by 0.82% and 77.07% in the 2 × 300 and 2 × 350 mg/kg groups, respectively. Haemonchus sp. was the highest percentage of collected larvae in all coproculture tests, ranging from 90 to 100%. In the third stage, there was no difference (P > 0.05) in the mean number of parasites between the OEO groups and the control. Although the decrease in EPG of more than 96% on D3 did not persist in the other evaluations, and immature forms and adult parasites were collected at slaughter, the EPG reduction of 77.07% on D14 with the dose of 700 mg/kg (OEO2 × 350) suggests that OEO can help to reduce the severity of parasitic infection and, consequently, to diminish pastures contamination, when used together with other methods to control gastrointestinal parasites in sheep.


Asunto(s)
Hemoncosis , Haemonchus , Aceites Volátiles , Enfermedades de las Ovejas , Animales , Hemoncosis/tratamiento farmacológico , Hemoncosis/parasitología , Hemoncosis/veterinaria , Aceites Volátiles/farmacología , Aceites Volátiles/uso terapéutico , Recuento de Huevos de Parásitos/veterinaria , Ovinos , Enfermedades de las Ovejas/tratamiento farmacológico , Enfermedades de las Ovejas/parasitología , Enfermedades de las Ovejas/prevención & control
4.
Vet Parasitol Reg Stud Reports ; 25: 100593, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-34474786

RESUMEN

The major compound in orange essential oil (OEO) is limonene, which has in vitro anthelmintic properties; however, a safe in vivo dose has not been defined for animals. Therefore, a pilot study was conducted to evaluate the effect of an OEO formulation for the control of gastrointestinal nematodes in sheep and to investigate adverse reactions in lambs after OEO administration. A total of 17 lambs received an oral OEO formulation at a concentration of 600 mg/mL, in doses of 200, 300, and 600 mg/kg. The most common clinical signs observed were head shaking (88.8%), backward head movement (51.1%), and ataxia (74.4%). Lambs treated with 600 mg/kg of OEO showed more severe combined clinical signs and longer duration of symptoms, presenting adverse reactions for up to 2 h after OEO administration. Testing of different doses and formulations with slower release of the active ingredient is recommended to minimize or eliminate these effects.


Asunto(s)
Antihelmínticos , Nematodos , Aceites Volátiles , Enfermedades de las Ovejas , Animales , Antihelmínticos/uso terapéutico , Aceites Volátiles/efectos adversos , Proyectos Piloto , Ovinos , Enfermedades de las Ovejas/tratamiento farmacológico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA